Pharmacokinetics of Intravenous Voriconazole in Obese Patients: Implications of CYP2C19 Homozygous Poor Metabolizer Genotype

There is a paucity of pharmacokinetic studies describing weight-based dosing of intravenous (IV) voriconazole in obesity. We report the pharmacokinetics of IV voriconazole in an obese CYP2C19 homozygous poor metabolizer and review previously reported data of IV voriconazole in obesity. A 17-year-old...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Moriyama, Brad, Jarosinski, Paul F., Figg, William D., Henning, Stacey A., Danner, Robert L., Penzak, Scott R., Wayne, Alan S., Walsh, Thomas J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3594083/
https://ncbi.nlm.nih.gov/pubmed/23400848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados